Shoulder Impingement SyndromeNCT05957952
The Effects of Dynamic Taping With Exercise on Neuromuscular Control in Individuals With Subacromial Impingement
A study of Shoulder Impingement Syndrome, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.
Trial summary
Background: Subacromial Impingement Syndrome (SIS) is the commonest disorder of the shoulder, accounting for 44%-65% of all complaints of shoulder pain. Previous studies have found kinematic changes and alterations in muscle activation amplitude or timing. Read more about this study
- Who is it for?
- Ages 20 to 40 years
- Conditions the study is for
- Shoulder Impingement Syndrome
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 34 participants
- Where
- 1 siteTaiwan
- Study dates
- 22 Nov 2023to 30 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Shoulder pain located on the front or outer side.
- The participants were only included if they were aged between 20-40 years.
- Total participation time in shoulder exercises per week is greater than or equal to 4 hours.
- Presence of scapular movement dysfunction.
- Presence of shoulder impingement symptoms, with at least 3 positive results in the following 6 tests:
- Painful arc test
Show all 11Show fewer
- Neer's impingement test
- Hawkins-Kennedy impingement test
- Empty can test
- Resisted external rotation test
- Tenderness of the rotator cuff tendons
Who cannot join
- Received shoulder exercise therapy in the past three months.
- Arm elevation angle less than 120 degrees
- Have a history of dislocation, fracture, or surgery of upper extremity
- A history of direct contact injury to the neck or upper extremities within the past 12 months
- A concussion within the past 12 months or a history of three or more concussions
- Brain injury and neurological impairment
- History of frequent headache or dizziness
- Contraindications to the use of transcranial magnetic stimulation, assessed with a safety screening questionnaire, including pregnancy, history of seizure, epilepsy and syncope, having cochlear implant, having medal implant and taking anti-depressant medication.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effects of Dynamic Taping With Exercise on Neuromuscular Control
Background: Subacromial Impingement Syndrome (SIS) is the commonest disorder of the shoulder, accounting for 44%-65% of all complaints of shoulder pain. Previous studies have found kinematic changes and alterations in muscle activation amplitude or timing. Recent studies also show the different organization of the corticospinal system in patients with SIS and alterations in central motor representation in individuals with rotator cuff tendinopathy. To restore kinematic changes and muscle activation in patients with SIS, treatments of patients with SIS commonly include motor control exercise and taping. However, there are different types of taping with different properties and purposes resulting in inconsistent outcomes. Recently, a new taping technique, Dynamic tape whose properties are between the most common taping Kinesio tape and rigid tape may solve the questions above. But the evidence of the effect of Dynamic tape and the additional effect of Dynamic tape with motor control exercises are still not well understood. Purpose: The purpose of this study is to investigate the additional effects of Dynamic taping with motor control exercise compared to motor control exercise alone on kinematic, muscle activity, corticospinal excitability, pain and function in people with subacromial Impingement Syndrome.
Methods: This is a randomized control trial. Fifty individuals with SIS will be randomly assigned into either an exercise group or dynamic tape with exercise group. Both groups will receive 5 sessions of treatment in 2 weeks, with 30 minutes per sessions. Outcomes will be measured at baseline, after the first intervention and following 2-week intervention. Primary outcome measures will include scapular kinematics, scapular muscle activation and corticospinal system. Secondary outcome measures included shoulder pain by a numeric pain rating scale and shoulder function by the disability of the arm, shoulder \& hand scale (DASH). Data analysis: two-way and three-way mixed ANOVA will used to compare the intervention effect of two groups.
- Conditions
- Shoulder Impingement Syndrome
- Being tested
- Motor control exercise with dynamic taping, Motor control exercise
- Keywords
- Shoulder Impingement Syndrome, Transcranial magnetic stimulation, Dynamic tape, Corticospinal system, Scapular control exercise, Kinematics, Muscle activation
- Medical subject headings
- Shoulder Impingement Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Motor control exercise with dynamic tapingProcedure or surgery
Subjects will learn how to control their scapula during motor control exercise with application of dynamic tape
Motor control exerciseProcedure or surgery
Subjects will learn how to control their scapula during motor control exercise without taping
| Study group | Role | What they receive |
|---|---|---|
| Exercise group | Sham comparator | Motor control exercise Receives: Procedure: Motor control exercise |
| Dynamic taping with exercise group | Experimental | Motor control exercise combined with dynamic taping Receives: Procedure: Motor control exercise with dynamic taping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Neurophysiological measures - Active motor threshold
Active motor threshold (AMT) will be described with the percentage (%) of maximum stimulator output (MSO).
Measured: Change from baseline AMT at the completion of the first 30-minute intervention
Neurophysiological measures - Active motor threshold
Active motor threshold (AMT) will be described with the percentage (%) of maximum stimulator output (MSO).
Measured: Change from baseline AMT at the completion of 5-session intervention, an average of 2 weeks
Neurophysiological measures - Motor evoked potential
Motor evoked potential (MEP) will be described with millivolt (mV).
Measured: Change from baseline MEP at the completion of the first 30-minute intervention
Neurophysiological measures - Motor evoked potential
Motor evoked potential (MEP) will be described with millivolt (mV).
Measured: Change from baseline MEP at the completion of 5-session intervention, an average of 2 weeks
Neurophysiological measures - Cortical silent period
Cortical silent period (CSP) will be measured with millisecond (ms).
Measured: Change from baseline CSP at the completion of the first 30-minute intervention
Neurophysiological measures - Cortical silent period
Cortical silent period (CSP) will be measured with millisecond (ms).
Measured: Change from baseline CSP at the completion of 5-session intervention, an average of 2 weeks
Neurophysiological measures - Short interval cortical inhibition
Short interval cortical inhibition (SICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms
Measured: Change from baseline SICI at the completion of the first 30-minute intervention
Neurophysiological measures - Short interval cortical inhibition
Short interval cortical inhibition (SICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms
Measured: Change from baseline SICI at the completion of 5-session intervention, an average of 2 weeks
Neurophysiological measures - Short interval cortical facilitation
Short interval cortical facilitation (SICF) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is above 5 ms
Measured: Change from baseline SICF at the completion of the first 30-minute intervention
Neurophysiological measures - Short interval cortical facilitation
Short interval cortical facilitation (SICF) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is above 5 ms
Measured: Change from baseline SICF at the completion of 5-session intervention, an average of 2 weeks
Secondary outcomes (6)
Scapular kinematics
Scapular kinematics, including anterior/posterior tilt, upward/downward rotation, and internal/external rotation in scapula plan elevation at 30°, 60°, 90°, and 120°, will be calculated and will be described with degree (°).
Measured: Change from baseline scapular kinematics at the completion of the first 30-minute intervention
Scapular kinematics
Scapular kinematics, including anterior/posterior tilt, upward/downward rotation, and internal/external rotation in scapula plan elevation at 30°, 60°, 90°, and 120°, will be calculated and will be described with degree (°).
Measured: Change from baseline scapular kinematics at the completion of 5-session intervention, an average of 2 weeks
Scapular muscles activation
The root mean square of electromyography (EMG) data of the upper trapezius, lower trapezius, and serratus anterior will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %) and calculated over three 30° increments of motion during arm elevation from 30° to 120°, including 30° - 60°, 60° - 90°, and 90° - 120°
Measured: Change from baseline scapular muscles activation at the completion of the first 30-minute intervention
Scapular muscles activation
The root mean square of electromyography (EMG) data of the upper trapezius, lower trapezius, and serratus anterior will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %) and calculated over three 30° increments of motion during arm elevation from 30° to 120°, including 30° - 60°, 60° - 90°, and 90° - 120°
Measured: Change from baseline scapular muscles activation at the completion of 5-session intervention, an average of 2 weeks
Shoulder function
Shoulder function will be measured by the disabilities of the arm, shoulder and hand (DASH) questionnaire, including the disability/symptom section (30 items, scored 1-5) and the optional high performance Sport/Music or Work section (4 items, scored 1-5). A higher score indicates greater disability.
Measured: Change from baseline DASH questionnaire at the completion of 5-session intervention, an average of 2 weeks
Visual analogue scale (VAS) of shoulder pain and instability
Shoulder pain and instability will be measured by visual analogue scale (VAS). Subjects need to mark the point that they feel represent their perception of their current state on a 10-cm line. Scores range from 0 (no symptom) to 100 (maximum symptom).
Measured: Change from baseline visual analogue scale at the completion of 5-session intervention, an average of 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2023
- Study start22 Nov 2023
- Primary completion28 Aug 2024
- Study completion30 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Shoulder Impingement SyndromeStudies of the same condition, open and under way.
- More trials run by National Yang Ming Chiao Tung UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Yang Ming Chiao Tung University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yin-Liang Lin, National Yang Ming Chiao Tung University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05957952
- Sponsor's protocol ID
- NYCU112007AF
- Status last verified
- Jun 2026
- First submitted
- 2 Jul 2023
- Last updated
- 30 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Dynamic Taping With Exercise on Neuromuscular Control
- ClinicalTrials.gov ID
- NCT05957952
- Acronym / sponsor ID
- NYCU112007AF
- Conditions
- Shoulder Impingement Syndrome
- Keywords
- Shoulder Impingement Syndrome, Transcranial magnetic stimulation, Dynamic tape, Corticospinal system, Scapular control exercise, Kinematics, Muscle activation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- National Yang Ming Chiao Tung UniversityUniversity, hospital or other
- Study start
- 22 Nov 2023 (actual)
- Primary completion
- 28 Aug 2024 (actual)
- Study completion
- 30 Sep 2024 (actual)
- First posted
- 24 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Subacromial Impingement Syndrome (SIS) is the commonest disorder of the shoulder, accounting for 44%-65% of all complaints of shoulder pain. Previous studies have found kinematic changes and alterations in muscle activation amplitude or timing. Recent studies also show the different organization of the corticospinal system in patients with SIS and alterations in central motor representation in individuals with rotator cuff tendinopathy. To restore kinematic changes and muscle activation in patients with SIS, treatments of patients with SIS commonly include motor control exercise and taping. However, there are different types of taping with different properties and purposes resulting in inconsistent outcomes. Recently, a new taping technique, Dynamic tape whose properties are between the most common taping Kinesio tape and rigid tape may solve the questions above. But the evidence of the effect of Dynamic tape and the additional effect of Dynamic tape with motor control exercises are still not well understood. Purpose: The purpose of this study is to investigate the additional effects of Dynamic taping with motor control exercise compared to motor control exercise alone on kinematic, muscle activity, corticospinal excitability, pain and function in people with subacromial Impingement Syndrome.
Methods: This is a randomized control trial. Fifty individuals with SIS will be randomly assigned into either an exercise group or dynamic tape with exercise group. Both groups will receive 5 sessions of treatment in 2 weeks, with 30 minutes per sessions. Outcomes will be measured at baseline, after the first intervention and following 2-week intervention. Primary outcome measures will include scapular kinematics, scapular muscle activation and corticospinal system. Secondary outcome measures included shoulder pain by a numeric pain rating scale and shoulder function by the disability of the arm, shoulder \& hand scale (DASH). Data analysis: two-way and three-way mixed ANOVA will used to compare the intervention effect of two groups.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Exercise group | Sham comparator | Procedure: Motor control exerciseMotor control exercise |
| Dynamic taping with exercise group | Experimental | Procedure: Motor control exercise with dynamic tapingMotor control exercise combined with dynamic taping |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (11 listed)
- Shoulder pain located on the front or outer side.
- The participants were only included if they were aged between 20-40 years.
- Total participation time in shoulder exercises per week is greater than or equal to 4 hours.
- Presence of scapular movement dysfunction.
- Presence of shoulder impingement symptoms, with at least 3 positive results in the following 6 tests:
Key exclusion criteria (8 listed)
- Received shoulder exercise therapy in the past three months.
- Arm elevation angle less than 120 degrees
- Have a history of dislocation, fracture, or surgery of upper extremity
- A history of direct contact injury to the neck or upper extremities within the past 12 months
- A concussion within the past 12 months or a history of three or more concussions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Motor control exercise with dynamic tapingSubjects will learn how to control their scapula during motor control exercise with application of dynamic tape | Procedure or surgery | Dynamic taping with exercise group |
| Motor control exerciseSubjects will learn how to control their scapula during motor control exercise without taping | Procedure or surgery | Exercise group |
Primary outcome
Neurophysiological measures - Active motor threshold
Time frame: Change from baseline AMT at the completion of the first 30-minute intervention
Active motor threshold (AMT) will be described with the percentage (%) of maximum stimulator output (MSO).
Neurophysiological measures - Active motor threshold
Time frame: Change from baseline AMT at the completion of 5-session intervention, an average of 2 weeks
Active motor threshold (AMT) will be described with the percentage (%) of maximum stimulator output (MSO).
Neurophysiological measures - Motor evoked potential
Time frame: Change from baseline MEP at the completion of the first 30-minute intervention
Motor evoked potential (MEP) will be described with millivolt (mV).
Neurophysiological measures - Motor evoked potential
Time frame: Change from baseline MEP at the completion of 5-session intervention, an average of 2 weeks
Motor evoked potential (MEP) will be described with millivolt (mV).
Neurophysiological measures - Cortical silent period
Time frame: Change from baseline CSP at the completion of the first 30-minute intervention
Cortical silent period (CSP) will be measured with millisecond (ms).
Neurophysiological measures - Cortical silent period
Time frame: Change from baseline CSP at the completion of 5-session intervention, an average of 2 weeks
Cortical silent period (CSP) will be measured with millisecond (ms).
Neurophysiological measures - Short interval cortical inhibition
Time frame: Change from baseline SICI at the completion of the first 30-minute intervention
Short interval cortical inhibition (SICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms
Neurophysiological measures - Short interval cortical inhibition
Time frame: Change from baseline SICI at the completion of 5-session intervention, an average of 2 weeks
Short interval cortical inhibition (SICI) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is below 5 ms
Neurophysiological measures - Short interval cortical facilitation
Time frame: Change from baseline SICF at the completion of the first 30-minute intervention
Short interval cortical facilitation (SICF) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is above 5 ms
Neurophysiological measures - Short interval cortical facilitation
Time frame: Change from baseline SICF at the completion of 5-session intervention, an average of 2 weeks
Short interval cortical facilitation (SICF) will be defined as percentage (%) of conditioning responses vs testing responses while the inter-stimulus interval is above 5 ms
6 secondary outcomes
Scapular kinematics
Time frame: Change from baseline scapular kinematics at the completion of the first 30-minute intervention
Scapular kinematics
Time frame: Change from baseline scapular kinematics at the completion of 5-session intervention, an average of 2 weeks
Scapular muscles activation
Time frame: Change from baseline scapular muscles activation at the completion of the first 30-minute intervention
Scapular muscles activation
Time frame: Change from baseline scapular muscles activation at the completion of 5-session intervention, an average of 2 weeks
Shoulder function
Time frame: Change from baseline DASH questionnaire at the completion of 5-session intervention, an average of 2 weeks
Visual analogue scale (VAS) of shoulder pain and instability
Time frame: Change from baseline visual analogue scale at the completion of 5-session intervention, an average of 2 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jun 2026.
Related trials for Shoulder Impingement Syndrome
Not yet recruiting
TECAR With Shoulder Chronic Shoulder Impingement Syndrome
Shoulder Impingement Syndrome
Recruiting
Device-Assisted Balance Training for People With Shoulder Impingement
Shoulder
Not yet recruiting
"Effectiveness of a Telerehabilitation Program Versus a Conventional Rehabilitation Program in Patients With Subacromial Pain"
Subacromial Impingement Syndrome
Active, not recruitingObservational study
Natural History of Shoulder Pathology in Manual Wheelchair Users
Paraplegia, Spinal Cord Injuries
Not yet recruiting
Spencer vs Positional Release Techniques for Chronic Subacromial Impingement
Chronic Subacromial Impingement Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study of Shoulder Impingement Syndrome, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Neurophysiological measures - Active motor threshold (time frame: Change from baseline AMT at the completion of the first 30-minute intervention). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2026.